3 completed. 3 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Completed 3 |
Follow Elsayed Abdelhalim Elsayed: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Flexible Ureteroscopy Versus Mini- Percutaneous Nephrolithotomy in Management of Pediatric Renal Stones Less Than 2 cm Group A :Flexible ureteroscope group, Group B : Mini perc group - Renal Stone, Pediatric | Not applicable | Completed | Elsayed Abdelhalim Elsayed | 60 | 2023-06-01 | 2026-10-15 |
| Management of OAB in Female Patients . Solfenacin, Mirabegron, Tadalafil 5mg - Overactive Bladder | Not applicable | Completed | Elsayed Abdelhalim Elsayed | 300 | 2022-09-14 | 2024-04-02 |
| Management of Lower Pole Renal Hard Stones ≤2 cm lithotripsy using Flexible ureteroscope, extracorporeal shock wave lithotripsy (ESWL), holmium laser lithotripsy using Karl® Storz MIP set - Renal Stones | Not applicable | Completed | Elsayed Abdelhalim Elsayed | 414 | 2022-03-01 | 2023-12-18 |
Nephrolithiasis (2) · Urinary Bladder, Overactive (1)
Lithotripsy (1) · Tadalafil (1) · mirabegron (1)
Egypt (3)